BeOne Medicines Statistics

Total Valuation

BeOne Medicines has a market cap or net worth of HKD 239.16 billion. The enterprise value is 228.04 billion.

Market Cap	239.16B
Enterprise Value	228.04B

Important Dates

The last earnings date was Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.43B
Shares Outstanding	n/a
Shares Change (YoY)	+0.78%
Shares Change (QoQ)	-2.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	75.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	100.22
PS Ratio	7.35
PB Ratio	8.85
P/TBV Ratio	9.27
P/FCF Ratio	n/a
P/OCF Ratio	188.67
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-74.23
EV / Sales	6.95
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-137.42

Financial Position

The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.32.

Current Ratio	1.95
Quick Ratio	1.64
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	-5.16
Interest Coverage	-18.93

Financial Efficiency

Return on equity (ROE) is -11.62% and return on invested capital (ROIC) is -3.86%.

Return on Equity (ROE)	-11.62%
Return on Assets (ROA)	-3.06%
Return on Invested Capital (ROIC)	-3.86%
Return on Capital Employed (ROCE)	-7.30%
Revenue Per Employee	2.96M
Profits Per Employee	-279,284
Employee Count	11,000
Asset Turnover	0.73
Inventory Turnover	1.35

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +59.45% in the last 52 weeks. The beta is 0.35, so BeOne Medicines's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	+59.45%
50-Day Moving Average	146.39
200-Day Moving Average	132.52
Relative Strength Index (RSI)	55.83
Average Volume (20 Days)	6,836,187

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BeOne Medicines had revenue of HKD 32.53 billion and -3.07 billion in losses. Loss per share was -29.20.

Revenue	32.53B
Gross Profit	27.63B
Operating Income	-2.17B
Pretax Income	-2.02B
Net Income	-3.07B
EBITDA	-811.59M
EBIT	-2.17B
Loss Per Share	-29.20

Full Income Statement

Balance Sheet

The company has 19.59 billion in cash and 8.57 billion in debt, giving a net cash position of 11.03 billion.

Cash & Cash Equivalents	19.59B
Total Debt	8.57B
Net Cash	11.03B
Net Cash Per Share	n/a
Equity (Book Value)	27.03B
Book Value Per Share	250.36
Working Capital	14.72B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.27 billion and capital expenditures -2.93 billion, giving a free cash flow of -1.66 billion.

Operating Cash Flow	1.27B
Capital Expenditures	-2.93B
Free Cash Flow	-1.66B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 84.94%, with operating and profit margins of -6.67% and -9.44%.

Gross Margin	84.94%
Operating Margin	-6.67%
Pretax Margin	-6.22%
Profit Margin	-9.44%
EBITDA Margin	-2.50%
EBIT Margin	-6.67%
FCF Margin	n/a

Dividends & Yields

BeOne Medicines does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.78%
Shareholder Yield	n/a
Earnings Yield	-1.28%
FCF Yield	-0.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a